Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $10.4 million.

  • cbdMD's Liabilities and Shareholders Equity fell 152.63% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.8 million, marking a year-over-year decrease of 2085.14%. This contributed to the annual value of $10.4 million for FY2025, which is 152.63% down from last year.
  • As of Q3 2025, cbdMD's Liabilities and Shareholders Equity stood at $10.4 million, which was down 152.63% from $9.9 million recorded in Q2 2025.
  • cbdMD's Liabilities and Shareholders Equity's 5-year high stood at $124.9 million during Q3 2021, with a 5-year trough of $9.9 million in Q2 2025.
  • For the 5-year period, cbdMD's Liabilities and Shareholders Equity averaged around $45.6 million, with its median value being $33.0 million (2023).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 1266.71% in 2021, then plummeted by 6733.6% in 2022.
  • cbdMD's Liabilities and Shareholders Equity (Quarter) stood at $99.3 million in 2021, then plummeted by 64.03% to $35.7 million in 2022, then tumbled by 57.75% to $15.1 million in 2023, then decreased by 23.53% to $11.5 million in 2024, then dropped by 9.73% to $10.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $10.4 million in Q3 2025, compared to $9.9 million in Q2 2025 and $10.9 million in Q1 2025.